Other drugmakers are looking to get a piece of the pie, given how quickly Zepbound’s sales are already growing, and analysts predict a significant increase in demand for anti-obesity medicines. Even …
This Unstoppable Growth Stock Just Delivered More Good News: Time to Buy?
view original post